Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-Market Observational Multi-Center Study to Evaluate the Effectiveness of Repeated QUTENZA Use in Adults With Painful Diabetic Peripheral Neuropathy of the Feet

NCT06495424 is registered in ClinicalTrials.gov with Averitas Pharma, Inc. as lead sponsor.

NCT NCT06495424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06495424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-Market Observational Multi-Center Study to Evaluate the Effectiveness of Repeated QUTENZA Use in Adults With Painful Diabetic Peripheral Neuropathy of the Feet
Lead sponsor
Averitas Pharma, Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
March 14, 2025
Completion date
March 1, 2027
Enrollment
144 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

painful diabetic neuropathy, peripheral diabetic neuropathy